New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Cancer patients should be told more about their fertility options

Cancer patients should be told more about their fertility options

by Medical Journal of AustraliaCredit: Drew Hays/UnsplashFertility preservation care for people with cancer is "often underimplemented" with barriers needing to be overcome, according to aut
Oncology December 18,2023
Cancer patients should be told more about their fertility options

Cancer patients should be told more about their fertility options

by Medical Journal of AustraliaCredit: Drew Hays/UnsplashFertility preservation care for people with cancer is "often underimplemented" with barriers needing to be overcome, according to aut
Oncology December 18,2023
Social vulnerability and medical skepticism top factors limiting adherence to screening

Social vulnerability and medical skepticism top factors limiting adherence to screening

byEuropean Society for Medical OncologySocial vulnerability showed to be a major limitation to participation in cancer screening for four tumors types—breast, cervical, colorectal and lung—accor
World medicine December 18,2023
Social vulnerability and medical skepticism top factors limiting adherence to screening

Social vulnerability and medical skepticism top factors limiting adherence to screening

byEuropean Society for Medical OncologySocial vulnerability showed to be a major limitation to participation in cancer screening for four tumors types—breast, cervical, colorectal and lung—accor
World medicine December 18,2023
Risk for psychiatric disorders up for spouses of patients with cancer

Risk for psychiatric disorders up for spouses of patients with cancer

by Elana GotkineSpouses of patients with cancer have an increased risk for psychiatric disorders, according to a study published online Jan. 5 inJAMA Network Open.Kejia Hu, M.D., from the Karoli
Psychiatry & Mental Health December 18,2023
Risk for psychiatric disorders up for spouses of patients with cancer

Risk for psychiatric disorders up for spouses of patients with cancer

by Elana GotkineSpouses of patients with cancer have an increased risk for psychiatric disorders, according to a study published online Jan. 5 inJAMA Network Open.Kejia Hu, M.D., from the Karoli
Psychiatry & Mental Health December 18,2023
Biomarker blood test confirms remission in patients with HPV+ oral cancer

Biomarker blood test confirms remission in patients with HPV+ oral cancer

byAmerican Society for Radiation OncologyA highly sensitive blood test that detects minute traces of cancer-specific DNA has been shown to accurately determine whether patients with HPV-related
Oncology December 18,2023
Biomarker blood test confirms remission in patients with HPV+ oral cancer

Biomarker blood test confirms remission in patients with HPV+ oral cancer

byAmerican Society for Radiation OncologyA highly sensitive blood test that detects minute traces of cancer-specific DNA has been shown to accurately determine whether patients with HPV-related
Oncology December 18,2023
Patients with cancer, suppressed immune system at high risk for severe COVID if treated with systemic drug therapies

Patients with cancer, suppressed immune system at high risk for severe COVID if treated with systemic drug therapies

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainPatients with cancer and a weakened immune system who are treated with immunotherapies tend to fare far worse from COVID-19 than t
Oncology December 18,2023
Patients with cancer, suppressed immune system at high risk for severe COVID if treated with systemic drug therapies

Patients with cancer, suppressed immune system at high risk for severe COVID if treated with systemic drug therapies

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainPatients with cancer and a weakened immune system who are treated with immunotherapies tend to fare far worse from COVID-19 than t
Oncology December 18,2023
Radiation/cisplatin combination established as standard of care for HPV+ oral cancer

Radiation/cisplatin combination established as standard of care for HPV+ oral cancer

byAmerican Society for Radiation OncologyCombinations of radiation and chemotherapy drugs have been shown to cure HPV-related head and neck cancer with a high success rate. A new phase III trial
Oncology December 18,2023
Radiation/cisplatin combination established as standard of care for HPV+ oral cancer

Radiation/cisplatin combination established as standard of care for HPV+ oral cancer

byAmerican Society for Radiation OncologyCombinations of radiation and chemotherapy drugs have been shown to cure HPV-related head and neck cancer with a high success rate. A new phase III trial
Oncology December 18,2023
Men with low-/intermediate-risk prostate cancer benefit from fewer, higher-dose radiation treatments

Men with low-/intermediate-risk prostate cancer benefit from fewer, higher-dose radiation treatments

byAmerican Society for Radiation OncologyStereotactic body radiation therapy (SBRT) is a safe and effective treatment for men with low- and intermediate-risk prostate cancer, according to a long
Oncology December 18,2023
Men with low-/intermediate-risk prostate cancer benefit from fewer, higher-dose radiation treatments

Men with low-/intermediate-risk prostate cancer benefit from fewer, higher-dose radiation treatments

byAmerican Society for Radiation OncologyStereotactic body radiation therapy (SBRT) is a safe and effective treatment for men with low- and intermediate-risk prostate cancer, according to a long
Oncology December 18,2023
Variants in BRCA1/2 and MMR genes in children with cancer

Variants in BRCA1/2 and MMR genes in children with cancer

by Stefan Zorn, Medizinische Hochschule HannoverProfessor Dr. Christian Kratz, initiator of the international study that investigated the cancer risk of disease-relevant variants in BRCA1/2 and MMR ge
Oncology December 18,2023
Variants in BRCA1/2 and MMR genes in children with cancer

Variants in BRCA1/2 and MMR genes in children with cancer

by Stefan Zorn, Medizinische Hochschule HannoverProfessor Dr. Christian Kratz, initiator of the international study that investigated the cancer risk of disease-relevant variants in BRCA1/2 and MMR ge
Oncology December 18,2023
Pelvic lymph node radiation provides significant benefit for prostate cancer patients

Pelvic lymph node radiation provides significant benefit for prostate cancer patients

byAmerican Society for Radiation OncologyThe first report of a large international clinical trial shows that, for men who show signs of prostate cancer after surgical removal of their prostates,
Oncology December 18,2023
Pelvic lymph node radiation provides significant benefit for prostate cancer patients

Pelvic lymph node radiation provides significant benefit for prostate cancer patients

byAmerican Society for Radiation OncologyThe first report of a large international clinical trial shows that, for men who show signs of prostate cancer after surgical removal of their prostates,
Oncology December 18,2023
Radiation therapy cuts low risk of recurrence in half for patients with 'good risk' breast cancer

Radiation therapy cuts low risk of recurrence in half for patients with 'good risk' breast cancer

by NRG OncologyA subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservation surgery but can lower that risk even further with radiationtherapy
Oncology December 18,2023
Radiation therapy cuts low risk of recurrence in half for patients with 'good risk' breast cancer

Radiation therapy cuts low risk of recurrence in half for patients with 'good risk' breast cancer

by NRG OncologyA subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservation surgery but can lower that risk even further with radiationtherapy
Oncology December 18,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com